People with early-onset Parkinson’s face challenges different from those with traditional late-onset Parkinson’s.

The US Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only subcutaneous apomorphine infusion device for the treatment of motor fluctuations in ...

Americans will soon have access to an infusion device that provides round-the-clock effective relief of Parkinson's disease.

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

AstraZeneca’s diabetes drug Bydureon (exenatide) has failed to slow the progression of Parkinson’s disease motor symptoms in a Phase III trial. The University College London (UCL) in the UK ...

It was found that the oral intake of the seaweed antioxidants restores motor ... Parkinson's symptoms over ... Caffeine Affects Brain Dopamine Function in Patients With Parkinson's Disease May ...

She was happily married, pregnant with her first child and had recently completed her residency in family medicine. Soon ...

“As the motor symptoms of Parkinson’s disease worsen over time, patients report alternating states between ON when their medication is working, and OFF when it’s not working optimally,” said Andrea ...

The FDA has approved the first and only subcutaneous apomorphine infusion device, apomorphine hydrochloride injection (Onapgo ...

According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately ...

Parkinson's Disease Treatment Market Aging Populations and Advancements in Deep Brain Stimulation, Gene Therapy, and Medications Fuel Marke ...